TARSUS PHARMACEUTICALS INC (TARS) Institutional Shareholders
TARSUS PHARMACEUTICALS INC (TARS) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $2.95B in TARS holdings during the latest filing period.
Blackrock, Inc. is currently the largest disclosed institutional shareholder of TARS tracked by InsiderSet, reporting ownership valued at approximately $242.71M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $301.13M, representing an estimated gain of +24.07% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 52% of the total disclosed TARS value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Deep Track Capital, Lp, Rtw Investments, Lp, and several other long-term asset managers with concentrated positions in TARSUS PHARMACEUTICALS INC (TARS).
This page ranks the largest institutional TARS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
250
Total Reported Value
$2.95B
Largest Holder
Blackrock, Inc.
Largest Position
$242.71M
Insider Transactions (90d)
16
Latest Filing Quarter
Q2 2026
New Institutional Positions
46
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Blackrock, Inc. | 0.00% | 3,856,137 | $242,705,264 | $301,125,738 | +$58,420,474 | +24.07% | |
| Deep Track Capital, Lp | 3.40% | 3,666,768 | $230,786,378 | $286,337,913 | +$55,551,535 | +24.07% | |
| Rtw Investments, Lp | 1.80% | 3,357,059 | $211,293,293 | $262,152,737 | +$50,859,444 | +24.07% | |
| Paradigm Biocapital Advisors Lp | 3.27% | 2,775,649 | $174,699,348 | $216,750,430 | +$42,051,082 | +24.07% | |
| Janus Henderson Group Plc | 0.08% | 2,240,963 | $157,222,823 | $174,996,801 | +$17,773,978 | +11.30% | |
| Morgan Stanley | 0.01% | 1,827,082 | $114,996,594 | $142,676,833 | +$27,680,239 | +24.07% | |
| Vanguard Capital Management Llc | 0.00% | 1,793,064 | $112,855,448 | $140,020,368 | +$27,164,920 | +24.07% | |
| Jennison Associates Llc | 0.06% | 1,663,655 | $104,710,448 | $129,914,819 | +$25,204,371 | +24.07% | |
| Tang Capital Management Llc | 4.48% | 1,568,266 | $98,706,662 | $122,465,892 | +$23,759,230 | +24.07% | |
| Millennium Management Llc | 0.06% | 1,427,124 | $89,823,185 | $111,444,113 | +$21,620,928 | +24.07% | |
| Bank Of America Corp | 0.00% | 1,193,182 | $75,098,874 | $93,175,582 | +$18,076,708 | +24.07% | |
| Geode Capital Management, Llc | 0.00% | 1,105,689 | $69,605,544 | $86,343,254 | +$16,737,710 | +24.05% | |
| State Street Corp | 0.00% | 1,072,951 | $67,531,536 | $83,786,744 | +$16,255,208 | +24.07% | |
| Vestal Point Capital, Lp | 1.54% | 1,050,000 | $66,087,000 | $81,994,500 | +$15,907,500 | +24.07% | |
| Assenagon Asset Management S.A. | 0.08% | 947,495 | $59,635,335 | $73,989,885 | +$14,354,550 | +24.07% | |
| Invesco Ltd. | 0.00% | 785,808 | $49,458,755 | $61,363,747 | +$11,904,992 | +24.07% | |
| Goldman Sachs Group Inc | 0.00% | 742,693 | $46,745,097 | $57,996,896 | +$11,251,799 | +24.07% | |
| Frazier Life Sciences Management, L.P. | 1.00% | 728,644 | $45,860,853 | $56,899,810 | +$11,038,957 | +24.07% | |
| D. E. Shaw & Co., Inc. | 0.03% | 710,559 | $44,722,583 | $55,487,552 | +$10,764,969 | +24.07% | |
| Fmr Llc | 0.00% | 672,949 | $42,355,422 | $52,550,587 | +$10,195,165 | +24.07% | |
| Nomura Asset Management International Inc. | 0.06% | 607,272 | $38,222,000 | $47,421,870 | +$9,199,870 | +24.07% | |
| Clearbridge Investments, Llc | 0.03% | 549,387 | $34,578,420 | $42,901,631 | +$8,323,211 | +24.07% | |
| Toronto Dominion Bank | 0.05% | 510,253 | $32,115,324 | $39,845,657 | +$7,730,333 | +24.07% | |
| Lord, Abbett & Co. Llc | 0.09% | 479,266 | $30,165,000 | $37,425,882 | +$7,260,882 | +24.07% | |
| Massachusetts Financial Services Co | 0.01% | 427,008 | $26,875,883 | $33,345,055 | +$6,469,172 | +24.07% | |
| Northern Trust Corp | 0.00% | 386,611 | $24,333,296 | $30,190,453 | +$5,857,157 | +24.07% | |
| Vanguard Portfolio Management Llc | 0.00% | 385,137 | $24,240,523 | $30,075,348 | +$5,834,825 | +24.07% | |
| Loomis Sayles & Co L P | 0.03% | 380,684 | $23,960,251 | $29,727,614 | +$5,767,363 | +24.07% | |
| Ensign Peak Advisors, Inc | 0.04% | 332,982 | $23,358,687 | $26,002,564 | +$2,643,877 | +11.32% | |
| Timessquare Capital Management, Llc | 0.34% | 369,377 | $23,248,588 | $28,844,650 | +$5,596,062 | +24.07% | |
| Wasatch Advisors Lp | 0.15% | 368,568 | $23,197,670 | $28,781,475 | +$5,583,805 | +24.07% | |
| Charles Schwab Investment Management Inc | 0.00% | 335,834 | $21,137,392 | $26,225,277 | +$5,087,885 | +24.07% | |
| Tri Locum Partners Lp | 2.54% | 328,340 | $20,665,720 | $25,640,071 | +$4,974,351 | +24.07% | |
| Mpm Bioimpact Llc | 1.24% | 322,007 | $20,267,121 | $25,145,527 | +$4,878,406 | +24.07% | |
| Driehaus Capital Management Llc | 0.12% | 317,576 | $19,988,233 | $24,799,510 | +$4,811,277 | +24.07% | |
| Squarepoint Ops Llc | 0.04% | 295,824 | $18,619,163 | $23,100,896 | +$4,481,733 | +24.07% | |
| Vanguard Fiduciary Trust Co | 0.00% | 286,289 | $18,019,030 | $22,356,308 | +$4,337,278 | +24.07% | |
| Artisan Partners Limited Partnership | 0.03% | 284,899 | $17,931,543 | $22,247,763 | +$4,316,220 | +24.07% | |
| Rock Springs Capital Management Lp | 0.85% | 277,087 | $17,439,856 | $21,637,724 | +$4,197,868 | +24.07% | |
| Price T Rowe Associates Inc | 0.00% | 260,784 | $16,415,000 | $20,364,623 | +$3,949,623 | +24.06% | |
| Citadel Advisors Llc | 0.01% | 241,737 | $15,214,927 | $18,877,242 | +$3,662,315 | +24.07% | |
| Bnp Paribas Financial Markets | 0.01% | 201,624 | $12,690,215 | $15,744,818 | +$3,054,603 | +24.07% | |
| Mackenzie Financial Corp | 0.01% | 191,428 | $12,048,478 | $14,948,613 | +$2,900,135 | +24.07% | |
| Parkman Healthcare Partners Llc | 0.97% | 150,000 | $9,441,000 | $11,713,500 | +$2,272,500 | +24.07% | |
| Jpmorgan Chase & Co | 0.00% | 139,981 | $8,683,850 | $10,931,116 | +$2,247,266 | +25.88% | |
| Allspring Global Investments Holdings, Llc | 0.01% | 130,329 | $7,935,733 | $10,177,392 | +$2,241,659 | +28.25% | |
| Seven Fleet Capital Management Lp | 1.31% | 117,067 | $7,909,873 | $9,141,762 | +$1,231,889 | +15.57% | |
| Caption Management, Llc | 0.27% | 120,700 | $7,596,858 | $9,425,463 | +$1,828,605 | +24.07% | |
| Jefferies Financial Group Inc. | 0.07% | 118,810 | $7,477,901 | $9,277,873 | +$1,799,972 | +24.07% | |
| First Trust Advisors Lp | 0.00% | 117,811 | $7,415,024 | $9,199,861 | +$1,784,837 | +24.07% |
Frequently asked questions about TARS
Who owns the most TARS stock?
The largest holders of TARS are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for TARSUS PHARMACEUTICALS INC (TARS).
Is TARS widely held by superinvestors?
Many widely followed stocks like TARS appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly TARS is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.